TrialDiabetes, obesity & metabolism2020

Association of increased hepatic insulin clearance and change in serum triglycerides or β-hydroxybutyrate concentration via the sodium/glucose-cotransporter 2 inhibitor tofogliflozin.

Yasuhiro Matsubayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.